Sensitivity of HIV-1 to neutralization by antibodies against O-linked carbohydrate epitopes despite deletion of O-glycosylation signals in the V3 loop

Archives of Virology

Volumn 141, Issue 2, 1996, Pages 291-300

  Hansen, J E S ^a   Jansson, B ^b   Gram, G J ^a   Clausen, H ^c   Nielsen, J O ^a   Olofsson, S ^b  

^a HVIDOVRE HOSPITAL   (Denmark)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; RECOMBINANT PROTEIN; SERINE; THREONINE;

AMINO ACID SEQUENCE; ARTICLE; BIOSYNTHESIS; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DELETION; GLYCOSYLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; MOLECULAR CLONING; MOLECULAR GENETICS; POINT MUTATION; PROTEIN SECONDARY STRUCTURE; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SITE DIRECTED MUTAGENESIS;

AMINO ACID SEQUENCE; CLONING, MOLECULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; GLYCOSYLATION; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NEUTRALIZATION TESTS; POINT MUTATION; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; SEQUENCE DELETION; SERINE; THREONINE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030019509     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01718400     Document Type: Article

References (20)

1. Back NKT, Smit L, De Jong J-J, Keulen W, Schutten M, Goudsmit J, Tersmette M (1994) An N-glycan within the human immunodeficiency virus type 1 gp 120 V3 loop affects virus neutralization. Virology 199: 431-438
2. Bernstein HB, Tucker SP, Hunter E, Schutzbach JS, Compans RW (1994) Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides. J Virol 68: 463-468
3. Clausen H, Pallesen T, Wandall H, Dabelsteen E, Hansen J-ES (1994) Simple mucin type O-glycans of HIV-1 : enzymatic prediction of glycosylation sites for vaccine construction. In: Bock K, Clausen H (eds) Complex carbohydrates in drug research. 36th Alfred Benzon Symposium, Copenhagen 1993, Munksgaard, pp 297-315
4. Hansen J-ES, Hofmann B, Pallesen T, Clausen H (1994) Rôle of carbohydrate on HIV and possibilities for anti-viral intervention. In: Bock K, Clausen H (eds) Complex carbohydrates in drug research. 36th Alfred Benzon Symposium, Copenhagen 1993, Munksgaard, pp 414-427
5. Hansen J-ES (1992) Carbohydrates of human immunodeficiency virus. APMIS 100: 96-108
6. Hansen J-ES, Clausen H, Hu S-L, Nielsen JO, Olofsson S (1992) An O-linked carbohydrate neutralization epitope of HIV gp120 is expressed by HIV env gene recombinant vaccinia virus without involvement of HIV regulatory genes. Arch Virol 126: 11-20
7. Hansen J-ES, Nielsen C, Arendrup M, Olofsson S, Mathiesen LR, Nielsen JO, Clausen H (1991) Broadly neutralizing antibodies targeted to mucin-type carbohydrate epitopes of human immunodeficiency virus. J Virol 65: 6461-6467
8. Harada S, Koyanagi Y, Yamamoto N (1985) Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229: 563-566
9. LaRosa GJ, Davide JP, Weinhold K, Waterbury JA, Profy AT, Lewis JA, Langlois AJ, Dreesman GR, Boswell RN, Shadduck P, Holley LH, Karplus M, Bolognesi DP (1990) Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science 249: 932-935
10. McCutchan JH, Pagano JS (1968) Enhancement of the infecticity of simian virus 40 deoxyribonucleic acid with diethyl-aminoethyl-dextran. J Natl Cancer Inst 41: 351-357
11. Moore JP, Jarret RF (1988) Sensitive ELISA for the gp120 and gp160 surface glycoproteins of HIV-1. AIDS Res Hum Retroviruses 5: 369-379
12. Moore JP, Sattentau QJ, Wyatt R, Sodroski J (1994) Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies. J Virol 68: 469-484
13. Moore JP, Wallace LA, Follett EA, McKeating JA (1988) An enzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1. AIDS 3: 155-163
14. Popovic M, Sarngadharan MG, Read E, Gallo RC (1984) Detection, isolation and continous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224: 497-500
15. Putney SD, McKeating JA (1990) Antigenic variation in HIV. AIDS 4 [Suppl 1]: 129-136
16. Reed LJ, Muench H (1938) A simple method of estimating fifty per cent endpoints. Am J Hyg 27: 493-497
17. Ricksteen A, Svenson C, Welinder C, Rymo L (1987) Identification of sequences in Epstein-Barr virus DNA required for the expression of the second Epstein-Barr virus-determined nuclear antigen in COS-1 cells. J Gen Virol 68: 2407-2418
18. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
19. Veronese FM, Reitz MS, Gupta G, Robert-Guroff M, Boyer-Thompson C, Louie A, Gallo RC, Lusso P (1993) Loss of a neutralizing epitope by a spontaneous point mutation in the V3 loop of HIV-1 isolated from an infected laboratory worker. J Biol Chem 268: 25894-25901
20. Åkerblom L, Hinkula J, Broliden PA, Mäkitalo B, Fridberger T, Rosen J, Vilacres-Eriksson M, Morein B, Wahren B (1990) Neutralizing cross-reactive and non- neutralizing monoclonal antibodies to HIV-1 gp 120. AIDS 4: 953-960